|
⚲
|
| Keyboard |
| Cerium Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001677995 |
| Sale | 2026-05-22 (2.5 M Offered, 0.8 M Sold) |
| Fund | |
| Phone | 7032292508 |
| Address | 312 Main Street Gaithersburg, MD 20878 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-08-06 (D) |
| Exemption | 506(b) |
| Remaining | $1,794,000 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| James Gale | Director | |
| Tom Depasquale | Director | |
| Robert Rubin | Director | |
| Steve Eskenazi | Director | |
| Peter Collum | Director | |
| Gregg Lapointe | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Wealthspire Advisors LP
✚
|
MD | |
|
Marshall Financial Group LLC
✚
|
MD | |
|
SPC Financial Inc
✚
|
MD | |
|
ABS Capital Partners Inc
✚
|
MD | |
|
Legg Mason Fund Adviser Inc
✚
|
MD | |
|
Roumell Asset Management LLC
✚
|
MD | |
|
Greenspring Associates LLC
✚
|
MD | |
|
Northpond Ventures LLC
✚
|
MD | |
|
Planning Solutions Group LLC
✚
|
MD | |
|
3 Strong Ships Capital LLC
✚
|
MD |